Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune MicroenvironmentAleksandar D. Kostic, Wendy S. Garrett, Eunyoung Chun et al.|Cell Host & Microbe|2013Cited by 2.7k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction CancerCharles S. Fuchs, Harry H. Yoon|JAMA Oncology|2018Cited by 1.8k
Long-Term Colorectal-Cancer Incidence and Mortality after Lower EndoscopyReiko Nishihara, Andrew T. Chan, Kana Wu et al.|New England Journal of Medicine|2013Cited by 1.5k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trialKohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al.|The Lancet|2018Cited by 1.3k
Postmenopausal Hormone Therapy and MortalityFrancine Grodstein, Frank E. Speizer, Meir J. Stampfer et al.|New England Journal of Medicine|1997Cited by 1.2k